Platte River Capital’s NxStage Medical Inc. NXTM Stock Holding History

Platte River Capital’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-23,000	Closed	-$329K	–	163
2015 Q2	$329K	Sell	23,000 -28,880	-56%	-$489K	0.17%	133
2015 Q1	$898K	Sell	51,880 -32,160	-38%	-$568K	0.4%	73
2014 Q4	$1.51M	Buy	84,040 +59,340	+240%	+$956K	0.56%	66
2014 Q3	$324K	Buy	+24,700	New	+$333K	0.08%	159
2014 Q1	–	Sell	-104,565	Closed	-$1.05M	–	232
2013 Q4	$1.05M	Sell	104,565 -52,065	-33%	-$591K	0.13%	147
2013 Q3	$2.06M	Buy	+156,630	New	+$2.05M	0.25%	121

Other funds holding NXTM

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

RIM

RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CAM

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

TCM

Tamarack Capital Management Carlsbad, California $840M AUM 19.47% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Platte River Capital's NXTM Position: Q3 2015 in Review

Platte River Capital sold out of NxStage Medical Inc. (NXTM) in Q3 2015, closing a stake of 23,000 shares — an estimated $329K sold.

Platte River Capital first reported a position in NXTM in Q3 2013 and held it in 6 quarters. The position peaked at $2.06M in Q3 2013. 127 funds tracked by Wall St. Rank hold NXTM as of Q3 2015.

Platte River Capital reported no remaining NxStage Medical Inc. position as of Q3 2015 after selling out during the quarter.
Platte River Capital sold 23,000 NxStage Medical Inc. shares in Q3 2015, an estimated $329K.
Platte River Capital first reported a position in NxStage Medical Inc. in Q3 2013 and held it in 6 quarters.
Platte River Capital's NxStage Medical Inc. position peaked at $2.06M in Q3 2013.
127 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2015.

Based on Platte River Capital's 13F filing for Q3 2015, filed 12 Nov 2015.